Patients’ SEP (EDI quintile) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
0 (least deprived) | 1 | 2 | 3 | 4 (most deprived) | |||||||
n | % | n | % | n | % | n | % | n | % | ||
Sex | Men | 74 | 59.68 | 71 | 68.27 | 70 | 55.12 | 86 | 62.77 | 63 | 63.00 |
Women | 50 | 40.32 | 33 | 31.73 | 57 | 44.88 | 51 | 37.23 | 37 | 37.00 | |
Age (median (interquartile range)) | 74 | 15.5 | 75 | 13.00 | 74 | 11.00 | 73 | 12.00 | 75 | 12.50 | |
Charlson comorbidity index | 0 | 59 | 47.58 | 51 | 49.04 | 54 | 42.52 | 61 | 44.53 | 36 | 36.00 |
1 | 27 | 21.77 | 20 | 19.23 | 21 | 16.54 | 26 | 18.98 | 28 | 28.00 | |
2+ | 19 | 15.32 | 18 | 17.31 | 22 | 17.32 | 30 | 21.90 | 15 | 15.00 | |
Undefinable | 19 | 15.32 | 15 | 14.42 | 30 | 23.62 | 20 | 14.60 | 21 | 21.00 | |
Performance status | 0/1 | 70 | 56.45 | 59 | 56.73 | 67 | 52.76 | 72 | 52.55 | 41 | 41.00 |
2 | 14 | 11.29 | 18 | 17.31 | 15 | 11.81 | 23 | 16.79 | 21 | 21.00 | |
3/4 | 8 | 6.45 | 10 | 9.62 | 15 | 11.81 | 16 | 11.68 | 11 | 11.00 | |
Undefinable | 32 | 25.81 | 17 | 16.35 | 30 | 23.62 | 26 | 18.98 | 27 | 27.00 | |
White blood cell (terticle | Low | 35 | 28.23 | 35 | 33.65 | 37 | 29.13 | 55 | 40.15 | 33 | 33.00 |
Medium | 43 | 34.68 | 36 | 34.62 | 44 | 34.65 | 38 | 27.74 | 28 | 28.00 | |
High | 44 | 35.48 | 33 | 31.73 | 41 | 32.28 | 41 | 29.93 | 34 | 34.00 | |
Undefinable | 2 | 1.61 | 0 | 0.00 | 5 | 3.94 | 3 | 2.19 | 5 | 5.00 | |
AML ontogeny | AML de novo | 74 | 59.68 | 51 | 49.04 | 63 | 49.61 | 73 | 53.28 | 40 | 40.00 |
Secondary AML (post treatment / MDS) | 46 | 37.10 | 49 | 47.12 | 59 | 46.46 | 60 | 43.80 | 54 | 54.00 | |
Undefinable | 4 | 3.23 | 4 | 3.85 | 5 | 3.94 | 4 | 2.92 | 6 | 6.00 | |
Cytogenetic prognosis | Favorable/Intermediate | 77 | 62.10 | 54 | 51.92 | 76 | 59.84 | 84 | 61.31 | 52 | 52.00 |
Unfavorable | 38 | 30.65 | 44 | 42.31 | 39 | 30.71 | 42 | 30.66 | 40 | 40.00 | |
Undefinable | 9 | 7.26 | 6 | 5.77 | 12 | 9.45 | 11 | 8.03 | 8 | 8.00 | |
Treatment | Intensive chemotherapy | 50 | 40.32 | 28 | 26.92 | 42 | 33.07 | 44 | 32.12 | 23 | 23.00 |
Low intensive therapy | 40 | 32.26 | 43 | 41.35 | 45 | 35.43 | 57 | 41.61 | 41 | 41.00 | |
Best supportive care | 34 | 27.42 | 33 | 31.73 | 40 | 31.50 | 36 | 26.28 | 36 | 36.00 |